Navigation Links
Omeros Announces Positive OMS721 Data in Model of Thrombotic Microangiopathy
Date:4/2/2013

aging technique that allows direct visualization of dynamic biological processes in the microcirculation in live animals, the effects of OMS721 on thrombus formation were assessed. Specifically, the study evaluated OMS721's ability to delay the time to onset of thrombus formation and to complete occlusion of the blood vessel. 100 percent of isotype-antibody control animals versus 71 percent of OMS721-treated animals showed thrombus formation, with the initiation of thrombus formation delayed approximately three-fold in the OMS721-treated group relative to control (a median of 19.0 vs. 6.8 minutes; p=0.0097). Eighty percent of control-treated animals showed complete occlusion within the observation period while only 43 percent of those treated with OMS721 occluded completely. Median time to complete occlusion was 18.0 minutes for control and 38.0 minutes for the OMS721-treated animals (p=0.0036).

"These data are impressive," stated Markus Sperandio , M.D., professor of cardiovascular physiology and microvascular disorders at the Walter-Brendel-Center of Experimental Medicine, Munich, Germany, where he conducted the TMA studies evaluating OMS721. "OMS721 looks like a promising agent to prevent thrombus formation in the microcirculation.  We are planning additional studies to refine the dosing and timing of administration of OMS721 in models across a wide range of thrombotic disorders."

"We are pleased with these results and are excited to initiate the clinical program for OMS721," stated Gregory A. Demopulos , M.D., chairman and chief executive officer of Omeros. "The current treatment options for aHUS are limited and, when compared to those options, we believe that OMS721 carries marked advantages that will translate to significant patient benefits.  We are eager to evaluate the drug product in aHUS patients, and we remain on track to begin Phase 1 clinical t
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omeros to Present at Deutsche Bank Securities Health Care Conference
2. Omeros Adds Four More Unlocked Orphan GPCRs to its Portfolio
3. Omeros to Present at Jefferies 2012 Global Healthcare Conference
4. Omeros Announces Proposed Public Offering of Common Stock
5. Omeros Prices $30 Million Public Offering of Common Stock
6. Omeros Announces Closing of $34.5 Million Public Offering of Common Stock
7. Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
8. Omeros Announces Discovery in MASP-2 Program
9. Omeros Corporation Reports Second Quarter 2012 Financial Results
10. Omeros Announces Completion of Enrollment in OMS103HP Phase 3 Clinical Trial
11. Omeros to Present at Two Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... 2015 La sofisticada aplicación ... sistemas de imagen por Ultrasonidos   ofrece resultados más ... rápidos y un flujo de trabajo   optimizado, lo ... proceso de detección de Cardiopatías   ... el lanzamiento europeo de HeartModel A.I ...
(Date:8/28/2015)... , Aug. 28, 2015  Delays in the ... can slow down the decision-making process, resulting in ... absolutely critical for biopharmaceutical companies to develop a ... process for quicker and more meaningful insights. ... Practices, LLC, nearly three-quarters of benchmarked study participants ...
(Date:8/28/2015)... 28, 2015 According to a ... (Breast, Lung, Prostate) Type (Protein & Genetic Biomarkers) Profiling ... Prognostic) & Geography - Global Forecast to 2020", published ... reach around 17,689.0 Million USD by 2020 at a ... to 2020. Browse 191 Tables and ...
Breaking Medicine Technology:Philips presenta HeartModel A.I en el Congreso ESC 2015 2Philips presenta HeartModel A.I en el Congreso ESC 2015 3Philips presenta HeartModel A.I en el Congreso ESC 2015 4Philips presenta HeartModel A.I en el Congreso ESC 2015 5Expediting the Pharmaceutical Market Research Process for Faster Insights 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 5
... , , STAMFORD, Conn., Jan. 8 ... (Nasdaq: SPDE ), today announced that Health Canada, ... the Zargis Cardioscan(TM) device for sale in Canada. , ... a Bluetooth®-enabled electronic stethoscope and is designed to help ...
... 8 Somanetics Corporation (Nasdaq: SMTS ) will release its ... 30, 2009 before the opening of the market on Thursday, January ... Company will host a conference call that will be webcast live ... On the conference call, Bruce Barrett, Somanetics, president and chief executive ...
Cached Medicine Technology:Zargis Cardioscan Cleared for Sale in Canada 2Zargis Cardioscan Cleared for Sale in Canada 3Somanetics Corporation to Release Fourth Quarter and Fiscal 2009 Financial Results and Host Conference Call January 21, 2010 2
(Date:8/31/2015)... ... August 31, 2015 , ... For 12 years, since ... acknowledged September 26th as Mesothelioma Awareness Day . On this day, and in ... several ways of becoming involved and helping the cause. , “One of the ways ...
(Date:8/31/2015)... ... August 31, 2015 , ... Westchester Insurance, ... Prairie, is teaming up with the Tarrant County chapter of Meals on Wheels ... Wheels is the oldest and largest national organization that supports the more than ...
(Date:8/31/2015)... ... 2015 , ... The Workgroup for Electronic Data Interchange ... to create efficiencies in healthcare information exchange, announces the agenda and open registration ... Hyatt Regency Reston in Reston, Va. from October 26-29, WEDI-Con will convene hundreds ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... Juvent Sports ... growing list of major sports figures who are finding joint pain relief after using ... former #1 men’s tennis player in the world said, “For the first time in ...
(Date:8/31/2015)... ... 2015 , ... PartnerTech hosted prospective businesses in ... a tour of their North American facility following the S.M.A.R.T Community Summit. PartnerTech ... business in the U.S. , The PartnerTech Inc. North American facility in ...
Breaking Medicine News(10 mins):Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 3Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 2Health News:Westchester Insurance and the Meals on Wheels Association Announce Joint Charity Effort to Provide Nutritious Meals for Senior Citizens 3Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 2Health News:Mats Wilander, 7 Grand Slam Title Winner and Tennis Legend, Now Plays Without Joint Pain 3Health News:PartnerTech Supports Economic Growth as Host 2
... David Brennan was elected board chairman of the Pharmaceutical Research ... meeting.In a speech to the meeting attendees, Brennan called on ... system to work together in a new collaborative and bipartisan ... , Increased ...
... Benefit the IP - Over $2,200 In Donations ... Verger, award-winning photographer and philanthropist is taking his ... to help raise awareness for the nonprofit Innocence ... grateful to Mr. Verger for using his considerable ...
... DEBRECEN, Hungary, April 3 Bertalan Mesko, medical blogger and ... that he presented in Nijmegen, The Netherlands at a Health ... shape the future of medicine. E-patients are patients who communicate ... information online and sometimes they are more up-to-date than their ...
... Holdings, Inc. (NYSE: ZMH ; SWX: ZMH) announced ... will be broadcast live over the Internet on Thursday, April ... release detailing the quarterly results will be made available at ... webcast can be accessed via Zimmer,s Investor Relations website at ...
... stems from discovery of mutation affecting infertility, , , THURSDAY, ... infertility in men could point the way to a ... , "We have identified CATSPER1 as a gene that ... finding which could lead to future infertility therapies that ...
... of neurodegenerative disease , , FRIDAY, April 3 (HealthDay News) ... to prevent brain cells from falling victim to the ... in the preliminary stages, and the researchers don,t know ... Huntington,s disease expert said the findings could lead to ...
Cached Medicine News:Health News:AstraZeneca's David Brennan Elected PhRMA Board Chairman 2Health News:AstraZeneca's David Brennan Elected PhRMA Board Chairman 3Health News:AstraZeneca's David Brennan Elected PhRMA Board Chairman 4Health News:Acclaimed New England Photographer Donald Verger Holds 'Faces of Innocence' Charity Event for the Innocence Project 2Health News:Genetic Finding May Lead to Male Contraceptive 2Health News:Scientists Uncover New Weapon Against Huntington's 2
... 1991 Intersurgical Incorporated manufactures ... heat and moisture exchangers, ... products, hand-held nebulizers and ... accessories and connectors for ...
... product line has the right product for ... and from intubated patients to patients with ... both anesthesia and critical care applications., ... protection for patients and staff members. This ...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Bacterial/Viral Filters for Anesthesia and Respiratory Applications...
Medicine Products: